(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

VITRACK

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

VITRACK

ST13

US500000097862354

Classe

10

Pedido

97862354

Registro

7590835

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

24

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

10

Data de depósito

29/03/2023

Data de registro

03/12/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

03/12/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

01/04/2023

Primeiro uso no comércio

01/04/2023

Código do desenho

4

Tipo de titular

03

Localização do titular

Lowell, MA, US

Examinador

RADEMACHER, APRIL LUEDERS

Unidade examinadora

L80

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Dynocardia, Inc.

Representantes

Mark M. Friedman Dr. Mark Friedman Ltd.

Classificação técnica

Classes Nice

Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 10

Health monitoring devices consisting of blood pressure monitors; blood pressure measuring equipment; wearable cuff-less arm monitors used to measure blood pressure, peripheral and central body temperature, heart rhythm, irregular heart rate, arrythmia, respiration, respiratory rate and respiratory patterns for medical use; wearable cuff-less arm monitors used to measure apnea, heart function, hemodynamics, cardiac output, cardiac filling pressures, central blood pressure, peripheral resistance, arterial stiffness, pulse transit time and tonometry for medical use; wearable cuff-less arm monitors used to measure arterial imaging, and venous imaging for medical use; medical instruments for recording heart activity, namely, electrocardiograms to diagnose and monitor peripheral and central body temperature, heart rhythm, irregular heart rate, arrythmia, respiration, respiratory rate, and respiratory patterns; medical instruments for recording heart activity, namely, electrocardiograms to diagnose and monitor apnea, heart function, hemodynamics, cardiac output, cardiac filling pressures, central blood pressure, peripheral resistance, arterial stiffness, pulse transit time, and tonometry; medical instruments for recording heart activity, namely, electrocardiograms to diagnose and monitor arterial imaging, and venous imaging; medical instruments for recording heart activity, namely, electrocardiograms to examine peripheral and central body temperature, heart rhythm, irregular heart rate, arrythmia, respiration, respiratory rate, and respiratory patterns; medical instruments for recording heart activity, namely, electrocardiograms to examine apnea, heart function, hemodynamics, cardiac output, cardiac filling pressures, central blood pressure, peripheral resistance, arterial stiffness, pulse transit time, and tonometry; medical instruments for recording heart activity, namely, electrocardiograms to examine arterial imaging, and venous imaging; medical sensors to be worn by a human to monitor blood pressure and heart rate data that can be transmitted for medical purposes to physicians; medical diagnostic, examination, and monitoring equipment, namely, electronic blood pressure monitors and electronic heart rate monitors; electronic medical instruments for recording blood pressure, heart rate, blood oxygen saturation; electronic medical instruments for measuring oxygen content of blood and electrocardiograms for measuring peripheral and central body temperature, heart rhythm, irregular heart rate, arrythmia, respiration, respiratory rate, respiratory patterns, apnea, heart function, hemodynamics, cardiac output, cardiac filling pressures, central blood pressure, peripheral resistance, arterial stiffness, pulse transit time, and tonometry; electrocardiograms for detecting arterial imaging, and venous imaging

Publicações

Histórico de despachos e eventos da marca no USPTO.

24 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/12/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

03/12/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/11/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/11/2024

EISU

TEAS STATEMENT OF USE RECEIVED

03/11/2024

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

03/11/2024

NREV

NOTICE OF REVIVAL - E-MAILED

03/11/2024

PETG

PETITION TO REVIVE-GRANTED

03/11/2024

PROA

TEAS PETITION TO REVIVE RECEIVED

03/11/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

28/10/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

28/10/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

28/10/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

28/10/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/04/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

13/02/2024

PUBO

PUBLISHED FOR OPPOSITION

13/02/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

24/01/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/01/2024

DOCK

ASSIGNED TO EXAMINER

22/12/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

17/06/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

17/06/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

17/06/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/04/2023

NWAP

NEW APPLICATION ENTERED

01/04/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace VITRACK ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.